Full-length dystrophin gene therapy for Duchenne muscular dystrophy is a research paper published in Molecular Therapy (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Neurological Disorders and Stroke
Grant: NS-131416
National Institute of Allergy and Infectious Diseases
Grant: AR-81018
National Institute of Allergy and Infectious Diseases
Grant: AI-177600
NIAMS NIH HHS
Grant: R21 AR081018
NIAID NIH HHS
Grant: R01 AI177600
NINDS NIH HHS
Grant: R01 NS131416
National Institutes of Health
FWCI
1.56
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords